The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Acorda Therapeutics, Inc. (ACOR)

NEW YORK--()--The Klein Law Firm announces the commencement of an investigation of Acorda Therapeutics, Inc. (NASDAQ: ACOR) concerning possible violations of federal securities laws. On November 15, 2017, Acorda revealed it had ceased enrolling new patients in its Phase 3 trial of its Parkinson’s treatment due to patient deaths.

If you suffered a loss in Acorda and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kkclasslaw.com/ACOR-Info-Request-Form-223.

Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

The Klein Law Firm
Joseph Klein, Esq.
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

Release Summary

The Klein Law Firm reminds investors of the commencement of an investigation of Acorda Therapeutics, Inc.

Contacts

The Klein Law Firm
Joseph Klein, Esq.
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com